{"success":true,"data":{"pressRelease":{"id":"166275","rtpr_id":"nGNE5gQjdH-20261012","ticker":"CMND","exchange":"NASDAQ","all_tickers":["CMND"],"title":"Clearmind: Charging Robotics Launches Next-Generation Automated EV-Charging Technology for Robotaxis and Autonomous Fleets","author":"Globe Newswire","published_at":"2026-10-12T11:55:00.207Z","article_body":"Vancouver, Canada, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc.\n(Nasdaq: CMND) (“Clearmind” or the \"Company\"), a clinical-stage biotech\ncompany focused on the discovery and development of novel, non-hallucinogenic,\nsecond generation psychedelic, neuroplastogen-derived therapeutics to solve\nmajor under-treated health problems, today announced that Charging Robotics\nLtd. (“Charging Robotics”), its 51%-owned subsidiary, has launched the\nnext generation of its autonomous vehicle charging platform, designed for\nrobotaxis, autonomous fleets and automated parking facilities.\n\nThe platform uses resonant inductive power transfer technology to transfer\nelectricity across an air gap without physical connectors. The system is\ndesigned to deliver charging power of up to 10 kW and achieve efficiency of up\nto 95% under specified operating conditions through the use of proprietary\ncoils, power electronics and control algorithms designed to support charging\nin environments with limited space and variable vehicle positioning.\n\nFor automated parking facilities, the technology is designed to enable\nelectric vehicles to charge automatically while stored in areas inaccessible\nto drivers, without requiring manual cable connections. For robotaxis and\nautonomous fleets, the platform uses a charging pad and an onboard receiver,\nallowing vehicles to charge without plug-in connections, robotic charging arms\nor dedicated docking maneuvers. The system is designed to initiate and record\ncharging sessions automatically, supporting unattended charging operations.\n\nThe platform also incorporates intelligent energy management and vehicle\ncommunication capabilities. By monitoring vehicle battery charge levels,\nvehicle types, onboard charging parameters, expected departure times and\ncharging preferences, its AI-driven scheduling system is designed to allocate\navailable power across multiple vehicles, prioritize charging needs and reduce\npeak electricity demand. The system also supports remote monitoring, charging\nreports and centralized management of charging infrastructure.\n\nWith the launch, Charging Robotics is presenting its technology for two\napplications: automated parking structures, where conventional plug-in\ncharging is impractical, and autonomous mobility operations, where vehicles\nneed to recharge between trips without human intervention. The platform is\nintended to address certain charging requirements associated with automated\nparking and autonomous vehicle operations.\n\nAbout Clearmind Medicine Inc.\n\nClearmind is a clinical-stage neuroplastogens pharmaceutical biotech company\nfocused on the discovery and development of non-hallucinogenic, second\ngeneration, neuroplastogen-derived therapeutics to solve widespread and\nunderserved health problems, including alcohol use disorder. Its primary\nobjective is to research and develop psychedelic-based compounds and attempt\nto commercialize them as regulated medicines, foods, or supplements.\n\nThe Company’s intellectual portfolio currently consists of nineteen patent\nfamilies, including 32 granted patents. The Company intends to seek additional\npatents for its compounds whenever warranted and will remain opportunistic\nregarding the acquisition of additional intellectual property to build its\nportfolio.\n\nShares of Clearmind are listed for trading on Nasdaq under the symbol \"CMND.\"\n\nFor further information, visit: https://www.clearmindmedicine.com or\ncontact:\n\nInvestor Relations\ninvest@clearmindmedicine.com\nwww.Clearmindmedicine.com\n\nForward-Looking Statements:\n\nThis press release contains “forward-looking statements” within the\nmeaning of the Private Securities Litigation Reform Act and other securities\nlaws. Words such as “expects,” “anticipates,” “intends,”\n“plans,” “believes,” “seeks,” “estimates” and similar\nexpressions or variations of such words are intended to identify\nforward-looking statements. For example, the Company is using forward-looking\nstatements when it discusses the capabilities, performance and anticipated\napplications of Charging Robotics’ autonomous vehicle charging platform; the\nplatform’s potential use in automated parking facilities, robotaxi\noperations and autonomous vehicle fleets; the ability of the platform’s\nenergy-management and vehicle-communication features to allocate available\npower, prioritize charging needs and reduce peak electricity demand; and the\ncontinued development, commercialization and market adoption of the platform.\nForward-looking statements are not historical facts, and are based upon\nmanagement’s current expectations, beliefs and projections, many of which,\nby their nature, are inherently uncertain. Such expectations, beliefs and\nprojections are expressed in good faith. However, there can be no assurance\nthat management’s expectations, beliefs and projections will be achieved,\nand actual results may differ materially from what is expressed in or\nindicated by the forward-looking statements. Forward-looking statements are\nsubject to risks and uncertainties that could cause actual performance or\nresults to differ materially from those expressed in the forward-looking\nstatements. For a more detailed description of the risks and uncertainties\naffecting the Company, reference is made to the Company’s reports filed\nfrom time to time with the Securities and Exchange Commission (“SEC”),\nincluding, but not limited to, the risks detailed in the Company’s annual\nreport on Form 20-F for the fiscal year ended October 31, 2025 and\nsubsequent filings with the SEC. Forward-looking statements speak only as of\nthe date the statements are made. The Company assumes no obligation to update\nforward-looking statements to reflect actual results, subsequent events or\ncircumstances, changes in assumptions or changes in other factors affecting\nforward-looking information except to the extent required by applicable\nsecurities laws. If the Company does update one or more forward-looking\nstatements, no inference should be drawn that the Company will make additional\nupdates with respect thereto or with respect to other forward-looking\nstatements. References and links to websites have been provided as a\nconvenience, and the information contained on such websites is not\nincorporated by reference into this press release. Clearmind is not\nresponsible for the contents of third-party websites.","article_body_html":"","raw_payload":{"data":{"id":"nGNE5gQjdH-20261012","title":"Clearmind: Charging Robotics Launches Next-Generation Automated EV-Charging Technology for Robotaxis and Autonomous Fleets","author":"Globe Newswire","ticker":"CMND","created":"2026-10-12T11:55:00.207Z","tickers":["CMND"],"exchange":"NASDAQ","article_body":"Vancouver, Canada, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc.\n(Nasdaq: CMND) (“Clearmind” or the \"Company\"), a clinical-stage biotech\ncompany focused on the discovery and development of novel, non-hallucinogenic,\nsecond generation psychedelic, neuroplastogen-derived therapeutics to solve\nmajor under-treated health problems, today announced that Charging Robotics\nLtd. (“Charging Robotics”), its 51%-owned subsidiary, has launched the\nnext generation of its autonomous vehicle charging platform, designed for\nrobotaxis, autonomous fleets and automated parking facilities.\n\nThe platform uses resonant inductive power transfer technology to transfer\nelectricity across an air gap without physical connectors. The system is\ndesigned to deliver charging power of up to 10 kW and achieve efficiency of up\nto 95% under specified operating conditions through the use of proprietary\ncoils, power electronics and control algorithms designed to support charging\nin environments with limited space and variable vehicle positioning.\n\nFor automated parking facilities, the technology is designed to enable\nelectric vehicles to charge automatically while stored in areas inaccessible\nto drivers, without requiring manual cable connections. For robotaxis and\nautonomous fleets, the platform uses a charging pad and an onboard receiver,\nallowing vehicles to charge without plug-in connections, robotic charging arms\nor dedicated docking maneuvers. The system is designed to initiate and record\ncharging sessions automatically, supporting unattended charging operations.\n\nThe platform also incorporates intelligent energy management and vehicle\ncommunication capabilities. By monitoring vehicle battery charge levels,\nvehicle types, onboard charging parameters, expected departure times and\ncharging preferences, its AI-driven scheduling system is designed to allocate\navailable power across multiple vehicles, prioritize charging needs and reduce\npeak electricity demand. The system also supports remote monitoring, charging\nreports and centralized management of charging infrastructure.\n\nWith the launch, Charging Robotics is presenting its technology for two\napplications: automated parking structures, where conventional plug-in\ncharging is impractical, and autonomous mobility operations, where vehicles\nneed to recharge between trips without human intervention. The platform is\nintended to address certain charging requirements associated with automated\nparking and autonomous vehicle operations.\n\nAbout Clearmind Medicine Inc.\n\nClearmind is a clinical-stage neuroplastogens pharmaceutical biotech company\nfocused on the discovery and development of non-hallucinogenic, second\ngeneration, neuroplastogen-derived therapeutics to solve widespread and\nunderserved health problems, including alcohol use disorder. Its primary\nobjective is to research and develop psychedelic-based compounds and attempt\nto commercialize them as regulated medicines, foods, or supplements.\n\nThe Company’s intellectual portfolio currently consists of nineteen patent\nfamilies, including 32 granted patents. The Company intends to seek additional\npatents for its compounds whenever warranted and will remain opportunistic\nregarding the acquisition of additional intellectual property to build its\nportfolio.\n\nShares of Clearmind are listed for trading on Nasdaq under the symbol \"CMND.\"\n\nFor further information, visit: https://www.clearmindmedicine.com or\ncontact:\n\nInvestor Relations\ninvest@clearmindmedicine.com\nwww.Clearmindmedicine.com\n\nForward-Looking Statements:\n\nThis press release contains “forward-looking statements” within the\nmeaning of the Private Securities Litigation Reform Act and other securities\nlaws. Words such as “expects,” “anticipates,” “intends,”\n“plans,” “believes,” “seeks,” “estimates” and similar\nexpressions or variations of such words are intended to identify\nforward-looking statements. For example, the Company is using forward-looking\nstatements when it discusses the capabilities, performance and anticipated\napplications of Charging Robotics’ autonomous vehicle charging platform; the\nplatform’s potential use in automated parking facilities, robotaxi\noperations and autonomous vehicle fleets; the ability of the platform’s\nenergy-management and vehicle-communication features to allocate available\npower, prioritize charging needs and reduce peak electricity demand; and the\ncontinued development, commercialization and market adoption of the platform.\nForward-looking statements are not historical facts, and are based upon\nmanagement’s current expectations, beliefs and projections, many of which,\nby their nature, are inherently uncertain. Such expectations, beliefs and\nprojections are expressed in good faith. However, there can be no assurance\nthat management’s expectations, beliefs and projections will be achieved,\nand actual results may differ materially from what is expressed in or\nindicated by the forward-looking statements. Forward-looking statements are\nsubject to risks and uncertainties that could cause actual performance or\nresults to differ materially from those expressed in the forward-looking\nstatements. For a more detailed description of the risks and uncertainties\naffecting the Company, reference is made to the Company’s reports filed\nfrom time to time with the Securities and Exchange Commission (“SEC”),\nincluding, but not limited to, the risks detailed in the Company’s annual\nreport on Form 20-F for the fiscal year ended October 31, 2025 and\nsubsequent filings with the SEC. Forward-looking statements speak only as of\nthe date the statements are made. The Company assumes no obligation to update\nforward-looking statements to reflect actual results, subsequent events or\ncircumstances, changes in assumptions or changes in other factors affecting\nforward-looking information except to the extent required by applicable\nsecurities laws. If the Company does update one or more forward-looking\nstatements, no inference should be drawn that the Company will make additional\nupdates with respect thereto or with respect to other forward-looking\nstatements. References and links to websites have been provided as a\nconvenience, and the information contained on such websites is not\nincorporated by reference into this press release. Clearmind is not\nresponsible for the contents of third-party websites."},"type":"article","timestamp":"2026-10-12T11:55:00.298334749Z","server_sent_at_ms":1791806100298},"received_at":"2026-10-12T11:55:00.348Z","source_url":null},"analysis":null,"durationMs":null,"modelName":null}}